Home COVID-19 Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19

Saturday, June 20, 2020

Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19

COVID-19
submitted by /u/zihua_
[link] [comments]

Artikel Terkait

Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19
4/ 5
Oleh
Komentar

Berlangganan

Suka dengan artikel di atas? Silakan berlangganan gratis via email


EmoticonEmoticon